
HCP access has narrowed by 36%. In-person interactions have dropped 65%. Two of three drug launches underperform expectations. Training completion is a logistics metric. Field readiness is a performance metric. Bayer, Novartis, and Sanofi already rebuilt their programs for the second.
Learn from the best. Inside the playbook:
If you are rebuilding pharma readiness for 2026 launches, this playbook shows what good looks like, and what three top-20 teams did to build it.
Download the playbook to see the model behind three top pharmaceutical companies, and how to bring it into yours.